EarningsQ2 2026 Earnings Report

IGC Pharma (IGS1) Q2 2026 Earnings Report

6 Followers

DE:IGS1 Q2 2026 EPS Results

Actual EPS-€0.02

Consensus EPS-€0.02

Beat/MissMet expectations

One Year Ago EPS-€0.02

Actual Revenue€170.44K

Expected Revenue€341.78K

Beat/MissMissed by -€171.34K

YoY Revenue Growth-53.64%

QuarterQ2 2026

Date11/17/2025

TimeBefore Open

Conference CallMonday, November 17, 2025

DE:IGS1 Upcoming Earnings

IGC Pharma's next earnings date is estimated for November 18, 2026, based on past reporting schedules.

DE:IGS1 Q2 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 18, 2026	2027 (Q2)	-0.02 / -	-0.018	―
Jun 15, 2026	2026 (Q4)	- / -0.02	-0.018	0.00% (0.00)
Mar 19, 2026	2026 (Q3)	-0.02 / >-0.01	-0.018	50.00% (<+0.01)
Nov 17, 2025	2026 (Q2)	-0.02 / -0.02	-0.018	0.00% (0.00)
Aug 19, 2025	2026 (Q1)	- / -	-0.027	―
Jun 30, 2025	2025 (Q4)	-0.02 / -0.02	-0.027	33.33% (<+0.01)
Feb 18, 2025	2025 (Q3)	-0.03 / -0.02	-0.08	77.78% (+0.06)
Nov 14, 2024	2025 (Q2)	-0.03 / -0.02	-0.045	60.00% (+0.03)
Aug 09, 2024	2025 (Q1)	-0.03 / -0.03	-0.035	23.08% (<+0.01)
Jun 24, 2024	2024 (Q4)	-0.04 / -0.03	-0.068	53.95% (+0.04)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed